U.S. jury orders Takeda to pay Bayer $155 million over hemophilia drug
(Reuters) – A U.S. jury has ordered Takeda Pharmaceutical Co’s Baxalta unit to pay Bayer AG $155.19 million for infringing a patent related to a Baxalta hemophilia treatment, court records…